Laura L. Parks - Jun 14, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Director
Signature
/s/ Ryan D. Lake
Stock symbol
SCTL
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 11:56 AM
Next filing
May 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCTL Stock Option (right to buy) Award $0 +20K $0.00 20K Jun 14, 2021 Common Stock 20K $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest in three equal annual installments, beginning on June 14, 2022, subject to the Reporting Person's continuous service with the Company.